Kolexia
Gargaun Elena Pédiatrie
Gargaun Elena
Pédiatrie
Centre Hospitalier du Mans
Le Mans, France
65 Activités
415 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Amyotrophie spinale Atrophie Amyotrophie Maladies musculaires Myopathies congénitales structurales Myopathie de Duchenne Dystrophies musculaires Amyotrophies spinales infantiles Hypotonie musculaire

Collaborateurs

Voir plus
Gidaro Teresa
Gidaro Teresa
Bioprojet Pharma, Paris, France
Servais Laurent
Servais Laurent
Hôpital Armand Trousseau, Paris, France
Seferian Andreea
Seferian Andreea
Hôpital Pitie Salpetriere, Paris, France
Vuillerot Carole
Vuillerot Carole
Hôpital Femme Mère Enfant, Bron, France

Industries

Voir plus
M3 Global Research Ltd
2 collaboration(s)
Dernière en 2021
ATHENEUM PARTNERS GMBH
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Expanded Access Program (EAP) for Nusinersen in Participants With Infantile-onset (Consistent With Type 1) Spinal Muscular Atrophy (SMA): Expanded Access Program (EAP) to Provide Nusinersen to Patients With Infantile-onset Spinal Muscular Atrophy (SMA)
Essai Clinique (Biogen)   01 avril 2021
The lncRNA 44s2 Study Applicability to the Design of 45-55 Exon Skipping Therapeutic Strategy for DMD.
Biomedicines   20 février 2021
DMD – BIOMARKERS & OUTCOME MEASURES: P.120 Phenotype and genotype characterization as predictors of DMD 45 to 55 multi-exon skipping therapy
Neuromuscular disorders : NMD   01 octobre 2020
Antisense oligonucleotides in SMA: lessons learned and literature data.
Medecine sciences : M/S   20 décembre 2019
P.335Phenotypic and genomic characterization as predictors of DMD 45 to 55 multi-exon skipping therapy
Neuromuscular disorders : NMD   01 octobre 2019
X-linked myotubular myopathy: A prospective international natural history study.
Neurology   22 mars 2019
SMA CLINICAL DATA, OUTCOME MEASURES AND REGISTRIES: P.88Associations between NMR, electrophysiological, strength and function variables in SMA type 2 and 3
Neuromuscular disorders : NMD   01 octobre 2018
Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: A cohort study.
Neurology   29 août 2018
MTM: Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Myotubular Myopathy (MTM)
Essai Clinique (Valerion Therapeutics, LLC)   06 juin 2018
miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context.
Skeletal muscle   27 avril 2018